Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial

    Shixiu Wu
    Shixiu Wu
    Changxing Lv
    Changxing Lv
    Anhui Shi
    Anhui Shi
    Wei Jiang
    Wei Jiang
    Yaping Xu
    Yaping Xu
    Jingbo Wang
    Jingbo Wang

    BMC cancer, pp. 2782020.

    Cited by: 0|Bibtex|Views12|Links
    WOS
    Keywords:
    ChemoradiotherapyECOG 2EfficacyLocally advancedNon-small-cell lung cancerMore(1+)

    Abstract:

    ClinicalTrials.gov registration number: NCT01494558. (Registered 19 December 2011).

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments